Original articles

Søraas A, Matsuyama M, de Lima M, Wald D, Buechner J, Gedde-Dahl T, Søraas CL, Chen B, Ferrucci L, Dahl JA, Horvath S, Matsuyama S (2019)
Epigenetic age is a cell-intrinsic property in transplanted human hematopoietic cells
Aging Cell, 18 (2), e12897
DOI 10.1111/acel.12897, PubMed 30712319

Bollestad M, Grude N, Solhaug S, Raffelsberger N, Handal N, Nilsen HS, Romstad MR, Emmert A, Tveten Y, Søraas A, Jenum PA, Jenum S, Møller-Stray J, Weme ET, Lindbaek M, Simonsen GS, (the Norwegian ESBL UTI study group) (2018)
Clinical and bacteriological efficacy of pivmecillinam treatment for uncomplicated urinary tract infections caused by ESBL-producing Escherichia coli: a prospective, multicentre, observational cohort study
J Antimicrob Chemother, 73 (9), 2503-2509
DOI 10.1093/jac/dky230, PubMed 29982514

Jørgensen SB, Søraas AV, Arnesen LS, Leegaard TM, Sundsfjord A, Jenum PA (2017)
A comparison of extended spectrum β-lactamase producing Escherichia coli from clinical, recreational water and wastewater samples associated in time and location
PLoS One, 12 (10), e0186576
DOI 10.1371/journal.pone.0186576, PubMed 29040337

Jørgensen SB, Søraas A, Arnesen LS, Leegaard T, Sundsfjord A, Jenum PA (2017)
First environmental sample containing plasmid-mediated colistin-resistant ESBL-producing Escherichia coli detected in Norway
APMIS, 125 (9), 822-825
DOI 10.1111/apm.12720, PubMed 28640456

Jørgensen SB, Søraas A, Sundsfjord A, Liestøl K, Leegaard TM, Jenum PA (2017)
Fecal carriage of extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae after urinary tract infection - A three year prospective cohort study
PLoS One, 12 (3), e0173510
DOI 10.1371/journal.pone.0173510, PubMed 28267783

Søraas AV (2015)
[ESBL – risk factors and treatment]
Tidsskr Nor Laegeforen, 135 (20), 1880
DOI 10.4045/tidsskr.15.0798, PubMed 26534823

Søraas A, Olsen I, Sundsfjord A, Handal T, Bjørang O, Jenum PA (2014)
Extended-spectrum beta-lactamase-producing bacteria are not detected in supragingival plaque samples from human fecal carriers of ESBL-producing Enterobacteriaceae
J Oral Microbiol, 6
DOI 10.3402/jom.v6.24026, PubMed 25206941

Søraas A, Sundsfjord A, Jørgensen SB, Liestøl K, Jenum PA (2014)
High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli
PLoS One, 9 (1), e85889
DOI 10.1371/journal.pone.0085889, PubMed 24454943

Søraas A, Sundsfjord A, Sandven I, Brunborg C, Jenum PA (2013)
Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country
PLoS One, 8 (7), e69581
DOI 10.1371/journal.pone.0069581, PubMed 23936052

Review articles

Gilmour BC, Gudmundsrud R, Frank J, Hov A, Lautrup S, Aman Y, Røsjø H, Brenner C, Ziegler M, Tysnes OB, Tzoulis C, Omland T, Søraas A, Holmøy T, Bergersen LH, Storm-Mathisen J, Nilsen H, Fang EF (2020)
Targeting NAD⁺ in translational research to relieve diseases and conditions of metabolic stress and ageing
Mech Ageing Dev, 186, 111208 (in press)
DOI 10.1016/j.mad.2020.111208, PubMed 31953124